201 related articles for article (PubMed ID: 1974728)
1. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Foxworthy PS; White SL; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728
[TBL] [Abstract][Full Text] [Related]
2. Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial beta-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase.
Mennes WC; Wortelboer HM; Hassing GA; van Sandwijk K; Timmerman A; Schmid BP; Jahn U; Blaauboer BJ
Arch Toxicol; 1994; 68(8):506-11. PubMed ID: 7802591
[TBL] [Abstract][Full Text] [Related]
3. Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver.
Cannon JR; Eacho PI
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):387-91. PubMed ID: 1747111
[TBL] [Abstract][Full Text] [Related]
4. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
[TBL] [Abstract][Full Text] [Related]
5. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
Gerondaes P; Alberti KG; Agius L
Biochem J; 1988 Jul; 253(1):161-7. PubMed ID: 3048253
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
[TBL] [Abstract][Full Text] [Related]
8. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
[TBL] [Abstract][Full Text] [Related]
10. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
[TBL] [Abstract][Full Text] [Related]
11. Conditions influencing the induction of peroxisomal beta-oxidation in cultured rat hepatocytes.
Foxworthy PS; Eacho PI
Toxicol Lett; 1986 Feb; 30(2):189-96. PubMed ID: 3458334
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
13. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Hong JT; Yun YP
Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes.
Cornu-Chagnon MC; Dupont H; Edgar A
Fundam Appl Toxicol; 1995 Jun; 26(1):63-74. PubMed ID: 7657063
[TBL] [Abstract][Full Text] [Related]
15. Induction of peroxisomal beta-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: structure-activity relationships.
Eacho PI; Foxworthy PS; Dillard RD; Whitesitt CA; Herron DK; Marshall WS
Toxicol Appl Pharmacol; 1989 Aug; 100(1):177-84. PubMed ID: 2763298
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
17. Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883.
Foxworthy PS; Perry DN; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Dec; 106(3):375-83. PubMed ID: 1979695
[TBL] [Abstract][Full Text] [Related]
18. Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate.
Yang JH; Kostecki PT; Calabrese EJ; Baldwin LA
Toxicol Appl Pharmacol; 1990 Jul; 104(3):476-82. PubMed ID: 2385837
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
